BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 12, 2020
View Archived Issues
Plexin D1 is receptor and mechanosensor in 1
Read More
Multiple edits make for durable T cells
Read More
The genetic architecture of tumors induced by high and low energy radiation in Trp53 deficient mice
Read More
Novartis studies BLZ-945 in phase II trial for ALS
Read More
TaiMed studies TMB-365 in first-in-human trial for HIV-1
Read More
FDA places clinical hold on the IND submission for LB-001
Read More
Positive top-line data from a phase II study of DAV-132
Read More
Plinabulin is a potent stimulator of the adaptive and innate immune system
Read More
TBX21 as a new genetic target in colorectal cancer
Read More
Prolactin could explain sex differences in pain syndromes
Read More
Roche patents new TLR antagonists
Read More
Cadila Healthcare discloses new compounds for tuberculosis
Read More
CVie Therapeutics and UNIMIB divulge compounds for heart failure
Read More
Faes Farma identifies new histamine H4 receptor antagonists
Read More
Esteve Pharmaceuticals discloses new analgesics
Read More
Phase IIb results presented for dalcinonacog alfa in hemophilia B patients
Read More
Xtandi significantly improves OS in PROSPER trial in non-metastatic CRPC
Read More
Aptorum reports data from IND-enabling studies of ALS-4 to treat S. aureus infections
Read More
Antios initiates first-in-human study of ATI-2173 for hepatitis B
Read More
Allena plans protocol amendment for second pivotal trial of reloxaliase for enteric hyperoxaluria
Read More
VistaGen reports preclinical data on AV-101 transport with adjunctive probenecid
Read More
